Patients with cervical cancer may under-report physical and emotional symptoms: a mixed-methods study of symptoms and quality-of-life to inform palliative care needs

Background: Despite high physical and emotional burdens, palliative care (PC) is underutilized in cervical cancer. There are limited data exploring patient perspectives on how treatments, symptoms and side effects contribute to PC needs. We investigated treatment experiences of patients with cervical cancer to determine potential PC strategies and intervention areas. Methods: We performed a convergent mixed methods study. Eligible patients were ≥18, English-speaking, with newly (≤12 months) diagnosed cervical cancer. Participants completed semi-structured interviews followed by the Functional Assessment of Cancer Therapy survey with cervix-specific sub-scale (FACT-Cx). Interviews were de-identified, professionally transcribed and coded. Descriptive statistics were performed for demographics and treatment information. Results: 17 patients participated. Most were white (11/17, 64.7%) and received radiation (11/17, 64.7%). Central interview themes were the significant impact of physical and emotional symptoms, a desire for on-going support services during periods of illness adjustment, and the high emotional toll of cervical cancer. Median scores on functional (18/28) and emotional (17/24) domains of the FACT-Cx were lowest. Pain and fatigue were the most reported symptoms. Patients disclosed more symptoms on the FACT-Cx than in interviews, particularly regarding mental health. Conclusions: Patients with recently diagnosed and treated cervical cancer reported high physical symptom burdens, rates of anxiety and depression, and need for social support. There was discrepancy in symptom reporting between qualitative and quantitative study components. Improved symptom screening, monitoring and assessment of psychosocial symptoms, and development of enhanced social support are priority areas in developing early integrated PC in this population.

Cervical cancer; Palliative care; Mixed methods; Quality of life

[1] Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA: A Cancer Journal for Clinicians. 2023; 73: 17–48.

[2] Cea García J, Rodríguez Jiménez I, Márquez Maraver F, Ríos-Pena L, Carmen Rubio Rodríguez M. Quality of life in long-term cervical cancer survivors compared with healthy women and women with benign gynecological disorders. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2024; 297: 78–85.

[3] Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA: A Cancer Journal for Clinicians. 2022; 72: 7–33.

[4] Ye S, Yang J, Cao D, Lang J, Shen K. A systematic review of quality of life and sexual function of patients with cervical cancer after treatment. International Journal of Gynecological Cancer. 2014; 24: 1146–1157.

[5] Ferrandina G, Mantegna G, Petrillo M, Fuoco G, Venditti L, Terzano S, et al. Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study. Gynecologic Oncology. 2012; 124: 389–394.

[6] Herzog TJ, Wright JD. The impact of cervical cancer on quality of life—the components and means for management. Gynecologic Oncology. 2007; 107: 572–577.

[7] Kirchheiner K, Pötter R, Tanderup K, Lindegaard JC, Haie-Meder C, Petrič P, et al. Health-related quality of life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy: an analysis from the EMBRACE study. International Journal of Radiation Oncology, Biology, Physics. 2016; 94: 1088–1098.

[8] Kumar S, Rana ML, Verma K, Singh N, Sharma AK, Maria AK, et al. PrediQt-Cx: post treatment health related quality of life prediction model for cervical cancer patients. PLOS ONE. 2014; 9: e89851.

[9] von Gruenigen VE, Daly BJ. Futility: clinical decisions at the end-of-life in women with ovarian cancer. Gynecologic Oncology. 2005; 97: 638–644.

[10] Lopez-Acevedo M, Havrilesky LJ, Broadwater G, Kamal AH, Abernethy AP, Berchuck A, et al. Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer. Gynecologic Oncology. 2013; 130: 156–161.

[11] Lewin SN, Buttin BM, Powell MA, Gibb RK, Rader JS, Mutch DG, et al. Resource utilization for ovarian cancer patients at the end of life: how much is too much? Gynecologic Oncology. 2005; 99: 261–266.

[12] Roberts JA, Brown D, Elkins T, Larson DB. Factors influencing views of patients with gynecologic cancer about end-of-life decisions. American Journal of Obstetrics and Gynecology. 1997; 176: 166–172.

[13] Fauci J, Schneider K, Walters C, Boone J, Whitworth J, Killian E, et al. The utilization of palliative care in gynecologic oncology patients near the end of life. Gynecologic Oncology. 2012; 127: 175–179.

[14] Hay CM, Lefkowits C, Crowley-Matoka M, Bakitas MA, Clark LH, Duska LR, et al. Gynecologic oncologist views influencing referral to outpatient specialty palliative care. International Journal of Gynecological Cancer. 2017; 27: 588–596.

[15] Hay CM, Lefkowits C, Crowley-Matoka M, Bakitas MA, Clark LH, Duska LR, et al. Strategies for introducing outpatient specialty palliative care in gynecologic oncology. Journal of Oncology Practice. 2017; 13: e712–e720.

[16] Sanders BS, Burkett TL, Dickinson GE, Tournier RE. Hospice referral decisions: the role of physicians. The American Journal of Hospice & Palliative Care. 2004; 21: 196–202.

[17] Cripe J, Mills K, Kuroki L, Wan L, Hagemann A, Fuh K, et al. Gynecologic oncologists’ perceptions of palliative care and associated barriers: a survey of the society of gynecologic oncology. Gynecologic and Obstetric Investigation. 2019; 84: 50–55.

[18] Wentlandt K, Krzyzanowska MK, Swami N, Rodin G, Le LW, Sung L, et al. Referral practices of pediatric oncologists to specialized palliative care. Supportive Care in Cancer. 2014; 22: 2315–2322.

[19] Salyer C, Littell RD, Pearl ML, Brown AJ, Popowich S, Lefkowits C, et al. Palliative care in gynecologic oncology: a narrative review of current literature and vision for the future. Annals of Palliative Medicine. 2022; 11: 3542–3554.

[20] Persenaire C, Spinosa DL, Brubaker LW, Lefkowits CJ. Incorporation of palliative care in gynecologic oncology. Current Oncology Reports. 2023; 25: 1295–1305.

[21] Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. Journal of Clinical Oncology. 1993; 11: 570–579.

[22] Vistad I, Fosså SD, Dahl AA. A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer. Gynecologic Oncology. 2006; 102: 563–572.

[23] Ashing-Giwa KT, Lim JW, Tang J. Surviving cervical cancer: does health-related quality of life influence survival? Gynecologic Oncology. 2010; 118: 35–42.

[24] Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qualitative Health Research. 2005; 15: 1277–1288.

[25] Bradley S, Rose S, Lutgendorf S, Costanzo E, Anderson B. Quality of life and mental health in cervical and endometrial cancer survivors. Gynecologic Oncology. 2006; 100: 479–486.

[26] Sorokin P, Kulikova S, Nikiforchin A, Ulrikh E. Impact of various treatment modalities on long-term quality of life in cervical cancer survivors. Cureus. 2024; 16: e68642.

[27] Brodeur MN, Dejean R, Beauchemin MC, Samouëlian V, Cormier B, Bacha OM, et al. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer. Gynecologic Oncology. 2021; 162: 277–283.

[28] Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, et al. Carcinoma of the cervix uteri. International Journal of Gynaecology and Obstetrics. 2006; 95: S43–S103.

[29] Tokarski AO, Bernardelli RS, Bruscato JR, Lucena CR, Linhares JC, Tsunoda AT. Quality of life post cervical cancer treatment: a comparison between radical surgery approach and radiotherapy and chemotherapy. Journal of Surgical Oncology. 2024; 130: 904–912.

[30] Hoppenot C, Littell RD, DeEulis T, Hartenbach EM. Top ten tips palliative care clinicians should know about caring for patients with cervical cancer. Journal of Palliative Medicine. 2021; 24: 438–442.

[31] Pozzar RA, Wall JA, Tavormina A, Thompson E, Enzinger AC, Matulonis UA, et al. Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers. Gynecologic Oncology. 2023; 181: 68–75.

[32] Maguire R, Kotronoulas G, Simpson M, Paterson C. A systematic review of the supportive care needs of women living with and beyond cervical cancer. Gynecologic Oncology. 2015; 136: 478–490.

[33] Jeppesen MM, Mogensen O, Dehn P, Jensen PT. Needs and priorities of women with endometrial and cervical cancer. Journal of Psychosomatic Obstetrics and Gynaecology. 2015; 36: 122–132.

[34] Toubassi D, Himel D, Winton S, Nyhof-Young J. The informational needs of newly diagnosed cervical cancer patients who will be receiving combined chemoradiation treatment. Journal of Cancer Education. 2006; 21: 263–268.

[35] Dos Santos LN, Castaneda L, de Aguiar SS, Thuler LCS, Koifman RJ, Bergmann A. Health-related quality of life in women with cervical cancer. Brazilian Journal of Gynecology and Obstetrics. 2019; 41: 242–248.

[36] Fernandes WC, Kimura M. Health related quality of life of women with cervical cancer. Latin American Journal of Nursing. 2010; 18: 360–367.

[37] Peerawong T, Suphasynth Y, Kongkamol C, Rordlamool P, Bridhikitti J, Jiratrachu R, et al. Validation of the functional assessment of cancer therapy with cervical cancer subscale (FACT-CX) for quality of life in Thai patients prior to chemoradiotherapy. Asian Pacific Journal of Cancer Prevention. 2020; 21: 1891–1897.

[38] Osann K, Hsieh S, Nelson EL, Monk BJ, Chase D, Cella D, et al. Factors associated with poor quality of life among cervical cancer survivors: implications for clinical care and clinical trials. Gynecologic Oncology. 2014; 135: 266–272.

[39] Bechthold AC, Azuero A, Pisu M, Pierce JY, Williams GR, Taylor RA, et al. The Project ENABLE Cornerstone randomized controlled trial: study protocol for a lay navigator-led, early palliative care coaching intervention for African American and rural-dwelling advanced cancer family caregivers. Trials. 2022; 23: 452.

[40] National Institutes of Health. SEER Cancer Stat Facts: Cervical Cancer. 2023. Available at: https://seer.cancer.gov/statfacts/html/cervix.html (Accessed: 02 January 2024).